Breaking News, Promotions & Moves

Executive Moves at Ori Biotech

Gillian Bonthron to serve as CFO, John Machulski as COO.

Ori Biotech Ltd., a company involved in cell and gene therapy (CGT) manufacturing technology, reported new additions to is executive team to support the commercial launch of its platform and the status of enrollment into their Lightspeed Early Access Program (LEAP). The company has appointed Gillian Bonthron chief financial officer, and John Machulski as chief operating officer. Bonthron joins Ori with expertise in transactional finance, financial strategy, and leadership within health tec...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters